Learning
July 20, 2021
We are currently refining and developing our internal training course curriculum for the remainder of 2021 into 2022. We can also reflect upon the courses delivered during the first half of 2021.
We are currently refining and developing our internal training course curriculum for the remainder of 2021 into 2022. We can also reflect upon the courses delivered during the first half of 2021.
We are thrilled to have Anna on board as an Associate Consultant. Her experience includes PK modeling and simulations for dosing individualization of antibodies and small molecules, and her publications include a
Pharmetheus is proud to have held a PK-Sim/MoBi workshop at the FDA. As members of the Open System Pharmacology Suite management team and of the scientific community, we partnered together with the
We are happy to welcome Maddlie Bardol to our growing team. Maddlie’s research experience includes population PK/PD modelling of analgesics and sedatives and dose optimization in children. Maddlie will take on a role as an associate consultant at
Our systems developer Quentin Leirens had performed the simulations and post-processing within this project with colleagues from Exprimo and Janssen, check out how this helped characterize the relationship between ponesimod plasma concentrations
Most welcome to our new colleague, Miha Purg, who joins us as System administrator, based in Uppsala. Miha’s experience includes administering HPC clusters, development of scientific software, and computational modelling of enzyme function, selectivity, and
How can confidence in generating realistic virtual subjects for clinical trial simulation be maintained when uncertainty about multivariate normal distribution assumptions exists? Pharmetheus consultants Giovanni Smania and Niclas Jonsson have investigated this and published about conditional
We are proud to have Mats Magnusson of Pharmetheus as co-author to the publication ‘Exposure-Efficacy Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung Disease’, accepted in the journal Respiratory Medicine.
Daniel Röshammar, Martin Bergstrand and Moustafa Ibrahim, of Pharmetheus are co-authors to the publication ‘Pharmacokinetic Modeling and Simulation Support for Age‐ and Weight‐Adjusted Dosing of Dabigatran Etexilate in Children with Venous Thromboembolism (VTE)’, accepted in
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..